DISEASE INDICATIONS: Risk of cardiovascular events
MANUFACTURER: Merck
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Verquvo (vericiguat) is a prescription medication used to treat chronic heart failure (CHF) with reduced ejection fraction (HFrEF). CHF is a condition in which the heart muscle is weakened and cannot pump blood as efficiently as it should. HFrEF is a type of CHF in which the left ventricle of the heart is not pumping blood as well as it should.
